Neurociencias - GIC 21/019
Universidad de Sevilla
Sevilla, EspañaPublikationen in Zusammenarbeit mit Forschern von Universidad de Sevilla (5)
2022
-
Drug-refractory myasthenia gravis: Clinical characteristics, treatments, and outcome
Annals of Clinical and Translational Neurology, Vol. 9, Núm. 2, pp. 122-131
-
Efficacy and safety clinical trial with efavirenz in patients diagnosed with adult Niemann-pick type C with cognitive impairment
Medicine (United States), Vol. 101, Núm. 48, pp. E31471
2021
-
Clinical characteristics and outcomes of thymoma-associated myasthenia gravis
European Journal of Neurology, Vol. 28, Núm. 6, pp. 2083-2091
-
Collaborative model for diagnosis and treatment of very rare diseases: experience in Spain with thymidine kinase 2 deficiency
Orphanet Journal of Rare Diseases, Vol. 16, Núm. 1
2019
-
Deoxynucleoside Therapy for Thymidine Kinase 2–Deficient Myopathy
Annals of Neurology, Vol. 86, Núm. 2, pp. 293-303